SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Brookside Capital Partners Fund LP – ‘4’ for 6/27/02 re: Bei Medical Systems Co. Inc./DE

On:  Wednesday, 7/10/02, at 9:56am ET   ·   For:  6/27/02   ·   Accession #:  927016-2-3589   ·   File #:  0-17885

Previous ‘4’:  ‘4’ on 6/14/02 for 5/10/02   ·   Next:  ‘4’ on 6/8/05 for 6/6/05   ·   Latest:  ‘4’ on 4/5/17 for 4/4/17

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/10/02  Brookside Cap Partners Fund LP    4          10% Owner   1:14K  Bei Medical Systems Co. Inc./DE   Donnelley Fin’l S… 07/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider   —   Form 4   —   SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Form 4 - Bei Medical Systems                           3     21K 

41st Page of 3TOCTopPreviousNextBottomJust 1st
 

=============================================================================== Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. /------------------------------/ / OMB APPROVAL / /------------------------------/ / OMB Number: 3235-0287 / / Expires: December 31, 2001 / / Estimated average burden / / hours per response...... 0.5 / /------------------------------/ +--------+ | FORM 4 | U.S. SECURITIES AND EXCHANGE COMMISSION +--------+ WASHINGTON, D.C. 20549 [X] Check this box if no longer subject STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP to Section 16. Form 4 or Form 5 Filed pursuant to Section 16(a) of the Securities obligations may Exchange Act of 1934, Section 17(a) of the continue. See Public Utility Holding Company Act of 1935 or Instruction 1(b). Section 30(f) of the Investment Company Act of 1940 (Print or Type Responses) -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Brakeman III Roy Edgar -------------------------------------------------------------------------------- (Last) (First) (Middle) 111 Huntington Avenue -------------------------------------------------------------------------------- (Street) Boston MA 02199 -------------------------------------------------------------------------------- (City) (State) (Zip) 2. Issuer Name and Ticker or Trading Symbol BEI Medical Systems Company, Inc. (BMED) ----------------------------------- 3. I.R.S. or Social Security Number of Reporting Person (voluntary) ---------------------------------------------------------------------------- 4. Statement for Month/Year July/2002 --------------------------------------------------- 5. If Amendment, Date of Original (Month/Year) --------------------------------- 6. Relationship of Reporting Person to Issuer (Check all applicable) ___ Director ___ Officer X 10% Owner ___ Other (give title below) --- (specify below) ---------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) ____ Form Filed by One Reporting Person X Form Filed by More than One Reporting Person ---- Table I--Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned [Enlarge/Download Table] ------------------------------------------------------------------------------------------------------------------------------------ 1. Title 2. Trans- 3. Trans- 4. Securities Acquired (A) 5. Amount of 6. Owner- 7. Nature of action action or Disposed of (D) Securities ship of In- Security Date Code (Instr. 3, 4 and 5) Beneficially Form: direct (Instr. 3) (Month/ (Instr. 8) Owned at Direct Bene- Day/ ----------------------------------------------- End of (D) or ficial Year) Month Indirect Owner- Code V Amount (A) or Price (Instr. 3 and 4) (I) ship (D) (Instr. 4) (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $6.8426 0 I (1) $.001 par value 6/27/02 U 1,328,633 D per share ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ (over) Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. *If the form is filed by more than one reporting person, see Instruction 4(b)(v). (Page 1 of 3)
42nd Page of 3TOC1stPreviousNextBottomJust 2nd
Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) [Enlarge/Download Table] ----------------------------------------------------------------------------------------------------------------------------- 1. Title of Derivative 2. Conver- 3. Trans- 4. Transac- 5. Number of Deriv- Security (Instr. 3) sion or action tion Code ative Securities Exercise Date (Instr. 8) Acquired (A) or Price of (Month/ Disposed of (D) Deriv- Day/ (Instr. 3, 4, and 5) ative Year) Security --------------------------------------------------- Code V (A) (D) ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------- Table II--Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)(continued) [Enlarge/Download Table] ------------------------------------------------------------------------------------------------------------------------------------ 6. Date Exer- 7. Title and Amount of 8. Price 9. Number 10. Owner- 11. Nature cisable and Underlying Securities of of Deriv- ship of indirect Expiration (Instr. 3 and 4) Deriv- ative Form Beneficial Date ative Secur- of De- Ownership (Month/Day/ Secur- ities rivative (Instr. 4) Year) ity Bene- Security: (Instr. ficially Direct (D) -------------------------------------------- 5) Owned or Indirect Date Expira- Amount or at End (I) Exer- tion Title Number of of (Instr. 4) cisable Date Shares Month (Instr. 4) ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------ /s/ Roy Edgar Brakeman, III July 09, 2002 ------------------------------- ----------------- **Signature of Reporting Person Date ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C.78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space provided is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. (Page 2 of 3)
4Last Page of 3TOC1stPreviousNextBottomJust 3rd
Attachment to Form 4 Pursuant to Instruction 5(b)(v) of the General Instructions to Form 4, this Form 4 is also being filed on behalf of the Reporting Persons set forth below. All of the information set forth in the attached Form 4 for Brookside Capital Management, LLC is the same for the Reporting Persons set forth below unless otherwise noted. Non-Derivative Securities [Enlarge/Download Table] Amount of Ownership Securities Securities Form: Nature of Disposed of Beneficially Direct Indirect (D) Owned at (D) or Beneficial Name and Address of Reporting Person Amount End of Month Indirect (I) Ownership -------------------------------------------------------------------------------------------------------------------- Brookside Capital Management, LLC 1,328,633 0 I (1) -------------------------------------------------------------------------------------------------------------------- Brookside Capital Investors, L.P. 1,328,633 0 I (1) -------------------------------------------------------------------------------------------------------------------- Brookside Capital Partners Fund, L.P. 1,328,633 0 D -------------------------------------------------------------------------------------------------------------------- (1) Roy Edgar Brakeman, III, as the sole managing member of Brookside Capital Management, LLC ("BCM"), BCM, as the sole general partner of Brookside Capital Investors, L.P. ("BCI"), and BCI, as the sole general partner of Brookside Capital Partners Fund, L.P. ("BCF"), may be deemed to share voting and dispositive power with respect to the shares held by BCF. Mr. Brakeman, BCM and BCI disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein. Signature of Reporting Persons: BROOKSIDE CAPITAL MANAGEMENT, LLC, for itself, on behalf of itself in its capacity as general partner of Brookside Capital Investors, L.P., and on behalf of Brookside Capital Investors, L.P. in its capacity as general partner of Brookside Capital Partners Fund, L.P. By: /s/ Roy Edgar Brakeman, III ---------------------------- Name: Roy Edgar Brakeman, III Title: Managing Director By: /s/ Roy Edgar Brakeman, III ---------------------------- Roy Edgar Brakeman, III (Page 3 of 3)

Dates Referenced Herein   and   Documents Incorporated by Reference

Referenced-On Page
This ‘4’ Filing    Date First  Last      Other Filings
Filed on:7/10/02SC 13G/A
7/9/022
For Period end:6/27/02SC 13D/A,  SC TO-T/A
12/31/01113F-NT
 List all Filings 
Top
Filing Submission 0000927016-02-003589   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 10:21:44.1am ET